1. Long-term survival after neoadjuvant therapy for triple-negative breast cancer under different treatment regimens: a systematic review and network meta-analysis
   Zhilin Liu et al, 2024, BMC Cancer CrossRef
2. Comparative efficacy and safety of first-line neoadjuvant treatments in triple-negative breast cancer: systematic review and network meta-analysis
   Jinming Li et al, 2022, Clinical and Experimental Medicine CrossRef
3. CUDC-907 enhances TRAIL-induced apoptosis through upregulation of DR5 in breast cancer cells
   Zhao-Jun Li et al, 2020, Journal of Cell Communication and Signaling CrossRef
4. Treatment for Triple-Negative Breast Cancer: An Umbrella Review of Meta-Analyses
   Jianyun Yin et al, 2022, International Journal of General Medicine CrossRef